• Luigi Mangione has withdrawn plans for a psychiatric defense in the murder case of UnitedHealthcare CEO Brian Thompson.
• His legal team initially aimed to argue he was experiencing "extreme emotional disturbance" at the time of the alleged crime.
• The reversal came just one day after notifying the court of their psychiatric defense intentions.
• The trial is scheduled to begin on September 8, with a potential federal trial date set for October 13.
• Public sentiment around the case remains intense due to underlying critiques of the health insurance industry.

Luigi Mangione, accused of murdering UnitedHealthcare CEO Brian Thompson, has dramatically withdrawn plans to assert a psychiatric defense at his upcoming state murder trial. His legal team informed Judge Gregory Carro of this decision through a letter on Thursday, only a day after they had signaled intentions to argue Mangione was suffering from "extreme emotional disturbance" during the alleged killing in December 2024 according to Reuters, BBC, NPR, and Los Angeles Times.

This withdrawal comes as Mangione's legal team faced a deadline to provide supporting psychiatric information to the prosecution. By not pursuing this defense, Mangione avoids having to disclose additional psychiatric evaluations, although legal experts suggest this could complicate his defense strategy at trial. The defense had originally indicated that if the jury accepted a psychiatric argument, Mangione might be convicted of manslaughter rather than murder, which carries much lighter penalties according to Reuters, BBC, NPR, and Los Angeles Times.

Former Manhattan prosecutor Gary Galperin remarked on the "stunning reversal", highlighting the uncertainty regarding what defensive strategy Mangione may now pursue. The legal landscape surrounding this high-profile case is under close scrutiny, particularly since it has attracted considerable public attention and discussion regarding health insurance practices, leading to a rather unusual public sentiment in Mangione's favor according to Reuters, BBC, NPR, and Los Angeles Times.

The trial is set to commence on September 8, with a trial on federal stalking charges expected to follow in October. Amid this complex legal situation, public and media interest remains high, especially considering the circumstances surrounding Thompson's death in a public setting and the broader implications for the healthcare industry according to Reuters, BBC, NPR, and Los Angeles Times.